{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:00:28Z","timestamp":1788274828128,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.hpb.2019.11.002","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T05:42:24Z","timestamp":1575265344000},"page":"497-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Systematic review of liver directed therapy for uveal melanoma hepatic metastases"],"prefix":"10.1016","volume":"22","author":[{"given":"Alistair","family":"Rowcroft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.T.","family":"Loveday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin N.J.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Banting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2019.11.002_bib1","doi-asserted-by":"crossref","first-page":"e18257","DOI":"10.1371\/journal.pone.0018257","article-title":"A\u00a0melanoma molecular disease model","volume":"6","author":"Vidwans","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2019.11.002_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","article-title":"The biology of uveal melanoma","volume":"36","author":"Amaro","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.hpb.2019.11.002_bib3","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.hpb.2019.11.002_bib4","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1200\/JCO.2005.02.6534","article-title":"Variates of survival in metastatic uveal melanoma","volume":"23","author":"Rietschel","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/1097-0142(197410)34:4<1001::AID-CNCR2820340406>3.0.CO;2-Z","article-title":"Metastatic patterns of choroidal melanoma","volume":"34","author":"Einhorn","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.11.002_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/1097-0142(19830715)52:2<334::AID-CNCR2820520225>3.0.CO;2-E","article-title":"Survival in metastatic ocular melanoma","volume":"52","author":"Rajpal","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.11.002_bib7","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Collaborative ocular melanoma study group. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: collaborative ocular melanoma study group report No. 26","volume":"123","author":"Diener-West","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.hpb.2019.11.002_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0161-6420(91)32285-1","article-title":"Survival of patients with metastases from uveal melanoma","volume":"98","author":"Gragoudas","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.hpb.2019.11.002_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/ceo.12490","article-title":"Survival from uveal melanoma in Western Australia 1981-2005","volume":"43","author":"Chew","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.hpb.2019.11.002_bib10","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ejca.2015.07.013","article-title":"Uveal melanoma UK national guidelines","volume":"51","author":"Nathan","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hpb.2019.11.002_bib11","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/1097-0142(19951101)76:9<1665::AID-CNCR2820760925>3.0.CO;2-J","article-title":"Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors","volume":"76","author":"Bedikian","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.11.002_bib12","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s00464-015-4527-9","article-title":"Laparoscopic management of liver metastases from uveal melanoma","volume":"30","author":"Akyuz","year":"2016","journal-title":"Surg Endosc"},{"key":"10.1016\/j.hpb.2019.11.002_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1245\/ASO.2005.06.032","article-title":"Treatment of liver metastases from uveal melanoma","volume":"12","author":"Rivoire","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib14","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ejso.2009.02.016","article-title":"Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie","volume":"35","author":"Mariani","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0748-7983(98)91485-8","article-title":"Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy","volume":"24","author":"Salmon","year":"1998","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ejso.2016.02.019","article-title":"Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma","volume":"42","author":"Mariani","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1499-3872(13)60095-8","article-title":"Treatment of liver metastases from uveal melanoma: a retrospective single-center analysis","volume":"12","author":"Yang","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hpb.2019.11.002_bib18","first-page":"2","article-title":"Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver","volume":"4","author":"Alexander","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.hpb.2019.11.002_bib19","first-page":"1","article-title":"The effect of perfusate buffering on toxicity and response in isolated hepatic perfusion for uveal melanoma liver metastases","author":"Ben-Shabat","year":"2017","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.hpb.2019.11.002_bib20","first-page":"3062","article-title":"A\u00a0phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver","volume":"6","author":"Alexander","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hpb.2019.11.002_bib21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1245\/s10434-015-4982-5","article-title":"Long-Term follow-up evaluation of 68 patients with uveal melanoma liver metastases treated with isolated hepatic perfusion","volume":"23","author":"Ben-Shabat","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008390-200402000-00011","article-title":"Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver","volume":"14","author":"Noter","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1016\/j.hpb.2019.11.002_bib23","first-page":"31","article-title":"Percutaneous isolated hepatic perfusion as a treatment for isolated hepatic metastases of uveal melanoma: patient outcome and safety in a multi-centre study","volume":"31","author":"Vogl","year":"2017","journal-title":"CVIR (Cardiovasc Interventional Radiol)"},{"key":"10.1016\/j.hpb.2019.11.002_bib24","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jso.24956","article-title":"Percutaneous hepatic perfusion with melphalan in uveal melanoma: a safe and effective treatment modality in an orphan disease","volume":"117","author":"Karydis","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/annonc\/mdt585","article-title":"Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial","volume":"25","author":"Leyvraz","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008390-200508000-00011","article-title":"Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study","volume":"15","author":"Patel","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1016\/j.hpb.2019.11.002_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/07357900802620893","article-title":"A\u00a0first report of radioembolization for hepatic metastases from ocular melanoma","volume":"27","author":"Kennedy","year":"2009","journal-title":"Cancer Invest"},{"key":"10.1016\/j.hpb.2019.11.002_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jvir.2014.11.037","article-title":"Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases","volume":"26","author":"Valsecchi","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.hpb.2019.11.002_bib29","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/jdv.12405","article-title":"MR-guided laser-induced thermotherapy (LITT) in patients with liver metastases of uveal melanoma","volume":"28","author":"Eichler","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.hpb.2019.11.002_bib30","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2147\/OPTH.S28863","article-title":"Current and emerging treatment options for uveal melanoma","volume":"7","author":"Pereira","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.hpb.2019.11.002_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","article-title":"Metastatic disease from uveal melanoma: treatment options and future prospects","volume":"101","author":"Carvajal","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"SUPPL","key":"10.1016\/j.hpb.2019.11.002_bib32","article-title":"Ipilimumab in the treatment of uveal melanoma: the memorial sloan-kettering cancer center experience","volume":"30","author":"Khan","year":"2012","journal-title":"J\u00a0Clin Oncol Conf"},{"key":"10.1016\/j.hpb.2019.11.002_bib33","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/cncr.28282","article-title":"Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the dana-farber cancer institute, Massachusetts general hospital, memorial sloan-kettering cancer center and university hospital of lausanne experience","volume":"119","author":"Luke","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.11.002_bib34","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1093\/annonc\/mdt376","article-title":"Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma","volume":"24","author":"Maio","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib35","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s11605-013-2295-1","article-title":"Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy","volume":"17","author":"Gur","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.11.002_bib36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4254\/wjh.v9.i5.242","article-title":"Role of surgical resection for non-colorectal non-neuroendocrine liver metastases","volume":"9","author":"Takemura","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hpb.2019.11.002_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.breast.2017.02.003","article-title":"Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: is there a survival benefit?","volume":"32","author":"Yoo","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.hpb.2019.11.002_bib38","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1002\/cncr.28743","article-title":"Surgical management of noncolorectal cancer liver metastases","volume":"120","author":"Page","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.11.002_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.exer.2012.04.010","article-title":"Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival","volume":"100","author":"Abdel-Rahman","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.hpb.2019.11.002_bib40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/bjc.2014.417","article-title":"Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing","volume":"111","author":"Kalirai","year":"2014","journal-title":"Br J Canc"},{"key":"10.1016\/j.hpb.2019.11.002_bib41","first-page":"128","article-title":"Quality of evidence about effectiveness of treatments for metastatic uveal melanoma","volume":"106","author":"Augsburger","year":"2008","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.hpb.2019.11.002_bib42","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/bjo.2008.153684","article-title":"Long-term survival of uveal melanoma patients after surgery for liver metastases","volume":"93","author":"Frenkel","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.hpb.2019.11.002_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bjophthalmol-2012-302323","article-title":"MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients","volume":"97","author":"Marshall","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.hpb.2019.11.002_bib44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jso.23535","article-title":"The Liverpool uveal melanoma liver metastases pathway: outcome following liver resection","volume":"109","author":"Gomez","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib45","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1245\/s10434-008-9881-6","article-title":"Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases","volume":"15","author":"van Iersel","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1245\/s10434-013-3304-z","article-title":"Isolated hepatic perfusion for ocular melanoma metastasis: registry data suggests a survival benefit","volume":"21","author":"Olofsson","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib47","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ejso.2014.06.010","article-title":"Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study","volume":"40","author":"van Iersel","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/CMR.0000000000000286","article-title":"Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres","volume":"26","author":"de Leede","year":"2016","journal-title":"Melanoma Res"},{"key":"10.1016\/j.hpb.2019.11.002_bib49","first-page":"22","article-title":"Phase II study of hepatic intraarterial fotemustine in patients with hepatic metastases from uveal malignant melanoma: preliminary results","volume":"5","author":"Leyvraz","year":"1992","journal-title":"Regional Cancer Treatment"},{"key":"10.1016\/j.hpb.2019.11.002_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/PL00012075","article-title":"Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients","volume":"6","author":"Egerer","year":"2001","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib51","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.bjc.6600521","article-title":"Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2","volume":"87","author":"Becker","year":"2002","journal-title":"Br J Canc"},{"key":"10.1016\/j.hpb.2019.11.002_bib52","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/annonc\/mdl009","article-title":"Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients","volume":"17","author":"Peters","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib53","first-page":"1157","article-title":"Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine","volume":"56","author":"Melichar","year":"2009","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.hpb.2019.11.002_bib54","first-page":"300","article-title":"Liver metastases from melanoma: hepatic intra-arterial chemotherapy. A retrospective study","volume":"23","author":"Farolfi","year":"2011","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.hpb.2019.11.002_bib55","first-page":"1151","article-title":"Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment","volume":"183","author":"Heusner","year":"2011","journal-title":"R\u00f6fo: Fortschritte dem Geb Rontgenstrahlen Nukl"},{"key":"10.1016\/j.hpb.2019.11.002_bib56","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jama.1988.03410070102037","article-title":"Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge","volume":"260","author":"Mavligit","year":"1988","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.hpb.2019.11.002_bib57","first-page":"173","article-title":"Chemoembolization of liver metastases from ocular melanoma: preliminary results","volume":"8","author":"Morassut","year":"1995","journal-title":"Reg Cancer Treat"},{"key":"10.1016\/j.hpb.2019.11.002_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00432-006-0155-z","article-title":"Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival","volume":"133","author":"Vogl","year":"2007","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib59","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/archophthalmol.2009.45","article-title":"Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization","volume":"127","author":"Dayani","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.hpb.2019.11.002_bib60","first-page":"131","article-title":"Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study","volume":"23","author":"Fiorentini","year":"2009","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.hpb.2019.11.002_bib61","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.ejrad.2009.03.064","article-title":"Transarterial chemoembolization of liver metastases in patients with uveal melanoma","volume":"74","author":"Huppert","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.hpb.2019.11.002_bib62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CMR.0b013e328334c36e","article-title":"Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome","volume":"20","author":"Schuster","year":"2010","journal-title":"Melanoma Res"},{"key":"10.1016\/j.hpb.2019.11.002_bib63","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2214\/AJR.11.7748","article-title":"Fotemustine chemoembolization of hepatic metastases from uveal melanoma: a retrospective single-center analysis","volume":"199","author":"Edelhauser","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.hpb.2019.11.002_bib64","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jvir.2012.04.027","article-title":"Transarterial chemoembolization with drug-eluting beads preloaded with irinotecan as a first-line approach in uveal melanoma liver metastases: tumor response and predictive value of diffusion-weighted MR imaging in five patients","volume":"23","author":"Venturini","year":"2012","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.hpb.2019.11.002_bib65","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/fon.12.191","article-title":"Repetitive chemoembolization of hypovascular liver metastases from the most common primary sites","volume":"9","author":"Farshid","year":"2013","journal-title":"Future Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tranon.2014.05.004","article-title":"Uveal melanoma metastatic to the liver: the role of quantitative volumetric contrast-enhanced MR imaging in the assessment of early tumor response after transarterial chemoembolization","volume":"7","author":"Duran","year":"2014","journal-title":"Translational Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib67","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00270-015-1093-4","article-title":"Transarterial chemoembolization of liver metastases from uveal melanoma using irinotecan-loaded beads: treatment response and complications","volume":"38","author":"Carling","year":"2015","journal-title":"CVIR (Cardiovasc Interventional Radiol)"},{"key":"10.1016\/j.hpb.2019.11.002_bib68","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2214\/AJR.14.14001","article-title":"Uveal melanoma metastatic to the liver: chemoembolization with 1,3-bis-(2-chloroethyl)-1-nitrosourea","volume":"205","author":"Gonsalves","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.hpb.2019.11.002_bib69","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/CMR.0000000000000129","article-title":"A\u00a0retrospective analysis of 141 patients with liver metastases from uveal melanoma: a two-cohort study comparing transarterial chemoembolization with CPT-11 charged microbeads and historical treatments","volume":"25","author":"Valpione","year":"2015","journal-title":"Melanoma Res"},{"key":"10.1016\/j.hpb.2019.11.002_bib70","first-page":"31","article-title":"Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population","volume":"31","author":"Shibayama","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib71","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2214\/AJR.10.4881","article-title":"Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience","volume":"196","author":"Gonsalves","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.hpb.2019.11.002_bib72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00270-012-0373-5","article-title":"Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients","volume":"36","author":"Klingenstein","year":"2013","journal-title":"CVIR (Cardiovasc Interventional Radiol)"},{"key":"10.1016\/j.hpb.2019.11.002_bib73","doi-asserted-by":"crossref","DOI":"10.1177\/2047981615570417","article-title":"A\u00a0single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma","volume":"4","author":"Schelhorn","year":"2015","journal-title":"Acta Radiologica Open"},{"key":"10.1016\/j.hpb.2019.11.002_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/COC.0000000000000033","article-title":"Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma: clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography","volume":"39","author":"Eldredge-Hindy","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/COC.0000000000000109","article-title":"Selective internal yttrium-90 radioembolization therapy (90Y-SIRT) versus best supportive care in patients with unresectable metastatic melanoma to the liver refractory to systemic therapy: safety and efficacy cohort study","volume":"40","author":"Xing","year":"2017","journal-title":"Am J Clin Oncol: Cancer Clin Trials"},{"key":"10.1016\/j.hpb.2019.11.002_bib76","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1200\/JCO.2008.16.0705","article-title":"Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor","volume":"26","author":"Sato","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.11.002_bib77","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1148\/radiol.2521081252","article-title":"High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma","volume":"252","author":"Yamamoto","year":"2009","journal-title":"Radiology"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19331934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19331934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:26:39Z","timestamp":1761265599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X19331934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1365182X19331934"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2019.11.002","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of liver directed therapy for uveal melanoma hepatic metastases","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}